We are live on ! Find out more
TNON icon

Tenon Medical

7 hedge funds and large institutions have $888K invested in Tenon Medical in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

11% more capital invested

Capital invested by funds: $798K → $888K (+$89.3K)

0.07% more ownership

Funds ownership: 0.01%0.08% (+0.07%)

30% less funds holding

Funds holding: 107 (-3)

43% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 7

Holders
7
Holders Change
-3
Holders Change %
-30%
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
1
Closed
7
Calls
Puts
Net Calls
Net Calls Change

TNON Hedge Fund Activity: Q4 2023 in Review

7 of the 6,863 institutional investors tracked by Wall St. Rank reported a position in Tenon Medical (TNON) for Q4 2023, worth a combined $888K — up 11% from $798K a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of TNON and 4 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was TMD Wealth Management, adding an estimated $123K. The largest seller was Spectrum Asset Management (California), cutting an estimated $44K.

  • 7 institutional investors held Tenon Medical (TNON) as of Q4 2023, down from 10 in Q3 2023.
  • Funds reported $888K of Tenon Medical stock for Q4 2023, up 11% quarter-over-quarter.
  • 4 funds opened new Tenon Medical positions in Q4 2023 and 7 closed out, a net change of -3 holders.
  • The largest Tenon Medical buyer in Q4 2023 was TMD Wealth Management, an estimated $123K added.
  • The largest Tenon Medical seller in Q4 2023 was Spectrum Asset Management (California), an estimated $44K sold.

Based on aggregated 13F filings for Q4 2023.